These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 8924270)
21. Effects of pioglitazone on glucose and lipid metabolism in normal and insulin resistant animals. Ikeda H; Taketomi S; Sugiyama Y; Shimura Y; Sohda T; Meguro K; Fujita T Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):156-62. PubMed ID: 2334455 [TBL] [Abstract][Full Text] [Related]
22. Characterization of an inhibitory effect of pioglitazone on balloon-injured vascular smooth muscle cell growth. Igarashi M; Hirata A; Yamaguchi H; Tsuchiya H; Ohnuma H; Tominaga M; Daimon M; Kato T Metabolism; 2001 Aug; 50(8):955-62. PubMed ID: 11474485 [TBL] [Abstract][Full Text] [Related]
23. Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia. Law RE; Meehan WP; Xi XP; Graf K; Wuthrich DA; Coats W; Faxon D; Hsueh WA J Clin Invest; 1996 Oct; 98(8):1897-905. PubMed ID: 8878442 [TBL] [Abstract][Full Text] [Related]
24. Proliferative effect of insulin on cultured smooth muscle cells from rat mesenteric resistance vessels. Cruzado M; Risler N; Castro C; Ortiz A; Rüttler ME Am J Hypertens; 1998 Jan; 11(1 Pt 1):54-8. PubMed ID: 9504450 [TBL] [Abstract][Full Text] [Related]
25. Effects of rosiglitazone on the proliferation of vascular smooth muscle cell induced by high glucose. Ling HY; Hu B; Wang BX; Zu XY; Feng SD; Ou HS; Zhou SH; Liao DF Cardiovasc Drugs Ther; 2008 Dec; 22(6):453-60. PubMed ID: 18665442 [TBL] [Abstract][Full Text] [Related]
26. Thiazolidinediones but not metformin directly inhibit the steroidogenic enzymes P450c17 and 3beta -hydroxysteroid dehydrogenase. Arlt W; Auchus RJ; Miller WL J Biol Chem; 2001 May; 276(20):16767-71. PubMed ID: 11278997 [TBL] [Abstract][Full Text] [Related]
27. Glyburide but not ciglitazone enhances insulin action in the liver independent of insulin receptor kinase activation. Caro JF; Ittoop O; Sinha MK Metabolism; 1989 Jul; 38(7):606-11. PubMed ID: 2544783 [TBL] [Abstract][Full Text] [Related]
28. [Inhibition of vascular smooth muscle cell proliferation by non-steroidal anti-inflammatory drugs]. Wang YQ; Brooks G; Harper J; Li YQ; Zhu CB; Yuan WZ; Wu XS Shi Yan Sheng Wu Xue Bao; 2003 Apr; 36(2):85-90. PubMed ID: 12858504 [TBL] [Abstract][Full Text] [Related]
29. Insulin action on protein phosphatase-1 activation is enhanced by the antidiabetic agent pioglitazone in cultured diabetic hepatocytes. Pugazhenthi S; Khandelwal RL Mol Cell Biochem; 1998 May; 182(1-2):185-91. PubMed ID: 9609128 [TBL] [Abstract][Full Text] [Related]
30. Effects of thiazolidinediones on growth and differentiation of human aorta and coronary myocytes. Morikang E; Benson SC; Kurtz TW; Pershadsingh HA Am J Hypertens; 1997 Apr; 10(4 Pt 1):440-6. PubMed ID: 9128211 [TBL] [Abstract][Full Text] [Related]
31. Pioglitazone-induced increase of insulin sensitivity in the muscles of the obese Zucker fa/fa rat cannot be explained by local adipocyte differentiation. Hallakou S; Foufelle F; Doaré L; Kergoat M; Ferré P Diabetologia; 1998 Aug; 41(8):963-8. PubMed ID: 9726600 [TBL] [Abstract][Full Text] [Related]
32. Effect of pioglitazone on L-NAME induced hypertension in diabetic rats. Majithiya JB; Parmar AN; Trivedi CJ; Balaraman R Vascul Pharmacol; 2005 Oct; 43(4):260-6. PubMed ID: 16168716 [TBL] [Abstract][Full Text] [Related]
33. Pioglitazone: cardiovascular effects in prediabetic patients. Mizushige K; Tsuji T; Noma T Cardiovasc Drug Rev; 2002; 20(4):329-40. PubMed ID: 12481203 [TBL] [Abstract][Full Text] [Related]
34. The effect of pioglitazone as add-on therapy to metformin or sulphonylurea compared to a fixed-dose combination of metformin and glibenclamide on diabetic dyslipidaemia. Comaschi M; Corsi A; Di Pietro C; Bellatreccia A; Mariz S; Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):373-9. PubMed ID: 17919894 [TBL] [Abstract][Full Text] [Related]
35. Blood pressure lowering by pioglitazone. Evidence for a direct vascular effect. Buchanan TA; Meehan WP; Jeng YY; Yang D; Chan TM; Nadler JL; Scott S; Rude RK; Hsueh WA J Clin Invest; 1995 Jul; 96(1):354-60. PubMed ID: 7615805 [TBL] [Abstract][Full Text] [Related]
36. Anti oxidant potential of Metformin and Pioglitazone in Type 2 Diabetes Mellitus: Beyond their anti glycemic effect. Singh RK; Gupta B; Tripathi K; Singh SK Diabetes Metab Syndr; 2016; 10(2):102-4. PubMed ID: 26341927 [TBL] [Abstract][Full Text] [Related]
37. Synergistic actions of insulin and troglitazone on contractility in endothelium-denuded rat aortic rings. Goud C; Pitt B; Webb RC; Richey JM Am J Physiol; 1998 Nov; 275(5):E882-7. PubMed ID: 9815009 [TBL] [Abstract][Full Text] [Related]
38. Evidence that pioglitazone, metformin and pentoxifylline are inhibitors of glycation. Rahbar S; Natarajan R; Yerneni K; Scott S; Gonzales N; Nadler JL Clin Chim Acta; 2000 Nov; 301(1-2):65-77. PubMed ID: 11020463 [TBL] [Abstract][Full Text] [Related]
39. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study. Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976 [TBL] [Abstract][Full Text] [Related]
40. Ultrasonography modifications of visceral and subcutaneous adipose tissue after pioglitazone or glibenclamide therapy combined with rosuvastatin in type 2 diabetic patients not well controlled by metformin. Maffioli P; Fogari E; D'Angelo A; Perrone T; Derosa G Eur J Gastroenterol Hepatol; 2013 Sep; 25(9):1113-22. PubMed ID: 23524525 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]